Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Multiple Sclerosis

Free Subscription Articles published in Neurology Retrieve available abstracts of 169 articles: HTML format

Single Articles

March 2008
1. FOLDEN DV , Lee MS, Ryan EH Jr
   INTERFERON {beta}-ASSOCIATED RETINOPATHY IN PATIENTS TREATED FOR MULTIPLE SCLEROSIS.
   Neurology. 2008;70.
   PubMed     Related articles   
   
   
   
2. MINDEN SL , Hoaglin DC, Hadden L, Frankel D, et al
   Access to and utilization of neurologists by people with multiple sclerosis.
   Neurology. 2008;70.
   PubMed     Related articles    Abstract available
   
   
   
3. POLMAN CH , Reingold SC, Barkhof F, Calabresi PA, et al
   Ethics of placebo-controlled clinical trials in multiple sclerosis: A reassessment.
   Neurology. 2008;70.
   PubMed     Related articles    Abstract available
   
   
   
4. BANWELL BL , Sled JG
   Starting early: MRI evidence of gray matter atrophy in children with multiple sclerosis.
   Neurology. 2008;70.
   PubMed     Related articles   
   
   
   February 2008
5. VERNY C , Loiseau D, Scherer C, Lejeune P, et al
   Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy.
   Neurology. 2008;.
   PubMed     Related articles   
   
   
   
6. HOFFMANN LA , Lohse P, Konig FB, Feneberg W, et al
   TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome.
   Neurology. 2008;.
   PubMed     Related articles   
   
   
   
7. MESAROS S , Rocca MA, Absinta M, Ghezzi A, et al
   Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
   Neurology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. DE JAGER PL , Simon KC, Munger KL, Rioux JD, et al
   Integrating risk factors. HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
   Neurology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. MALUCCHI S , Gilli F, Caldano M, Marnetto F, et al
   Predictive markers for response to interferon therapy in patients with multiple sclerosis.
   Neurology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. GHAFFAR O , Feinstein A
    Multiple sclerosis and cannabis. A cognitive and psychiatric study.
    Neurology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
11. LEVY M , Birnbaum J, Kerr D
    Finding NMO: neuromyelitis optica in children.
    Neurology. 2008;70:334-5.
    PubMed     Related articles   
    
    
    
12. LASSMANN H , Lucchinetti CF
    Cortical demyelination in CNS inflammatory demyelinating diseases.
    Neurology. 2008;70:332-3.
    PubMed     Related articles   
    
    
    
13. ESPINOSA PS
    Teaching NeuroImage: one-and-a-half syndrome.
    Neurology. 2008;70:e20.
    PubMed     Related articles   
    
    
    
14. BANWELL B , Tenembaum S, Lennon VA, Ursell E, et al
    Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders.
    Neurology. 2008;70:344-52.
    PubMed     Related articles    Abstract available
    
    
    
15. PHILLIPS MD
    Functional faults: fMRI in MS.
    Neurology. 2008;70:248-9.
    PubMed     Related articles   
    
    
    
16. ROCCA MA , Tortorella P, Ceccarelli A, Falini A, et al
    The "mirror-neuron system" in MS: A 3 tesla fMRI study.
    Neurology. 2008;70:255-62.
    PubMed     Related articles    Abstract available
    
    
    
17. SADOVNICK AD , Jacobs DH
    MS and cognition and APOE: the ongoing conundrum about biomarkers.
    Neurology. 2008;70:164-5.
    PubMed     Related articles   
    
    
    
18. FEYS P , Helsen W, Nuttin B, Lavrysen A, et al
    Unsteady gaze fixation enhances the severity of MS intention tremor.
    Neurology. 2008;70:106-13.
    PubMed     Related articles    Abstract available
    
    
    
19. FONTAINE B , Barcellos LF
    Evidence for a complex interaction between HLA-DRB1 and environmental factors in MS.
    Neurology. 2008;70:97-8.
    PubMed     Related articles   
    
    
    December 2007
20. HINSON SR , Pittock SJ, Lucchinetti CF, Roemer SF, et al
    Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
    Neurology. 2007;69:2221-31.
    PubMed     Related articles    Abstract available
    
    
    
21. DEAN G , Yeo TW, Goris A, Taylor CJ, et al
    HLA-DRB1 and multiple sclerosis in Malta.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. ROCCA MA , Pagani E, Absinta M, Valsasina P, et al
    Altered functional and structural connectivities in patients with MS: a 3-T study.
    Neurology. 2007;69:2136-45.
    PubMed     Related articles    Abstract available
    
    
    
23. FROHMAN EM , Zivadinov R
    What you see is what you get: coupling function with structure in the visual system.
    Neurology. 2007;69:2119-20.
    PubMed     Related articles   
    
    
    
24. 
    Highlights of the December 4 issue.
    Neurology. 2007;69:2115.
    PubMed     Related articles   
    
    
    November 2007
25. PULICKEN M , Gordon-Lipkin E, Balcer LJ, Frohman E, et al
    Optical coherence tomography and disease subtype in multiple sclerosis.
    Neurology. 2007;69:2085-92.
    PubMed     Related articles    Abstract available
    
    
    
26. ZHAO Y , Traboulsee A, Petkau AJ, Li D, et al
    Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
27. DE STEFANO N , Filippi M, Miller D, Pouwels PJ, et al
    Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.
    Neurology. 2007;69:1942-52.
    PubMed     Related articles    Abstract available
    
    
    October 2007
28. GORDON-LIPKIN E , Chodkowski B, Reich DS, Smith SA, et al
    Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
    Neurology. 2007;69:1603-9.
    PubMed     Related articles    Abstract available
    
    
    
29. WAXMAN SG , Black JA
    Retinal involvement in multiple sclerosis.
    Neurology. 2007;69:1562-3.
    PubMed     Related articles   
    
    
    
30. KOCH M , van Harten A, Uyttenboogaart M, De Keyser J, et al
    Cigarette smoking and progression in multiple sclerosis.
    Neurology. 2007;69:1515-20.
    PubMed     Related articles    Abstract available
    
    
    
31. TROJANO M
    Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?
    Neurology. 2007;69:1478-9.
    PubMed     Related articles   
    
    
    
32. PACHNER AR
    Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology. 2007;69:1555.
    PubMed     Related articles   
    
    
    
33. POLMAN CH , Deisenhammer F, Giovannoni G, Killestein J, et al
    Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology. 2007;69:1553-4.
    PubMed     Related articles   
    
    
    
34. SORENSEN PS , Bertolotto A
    Re: Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology. 2007;69:1552.
    PubMed     Related articles   
    
    
    
35. KATIRJI B
    Teaching NeuroImage: the L5 spinal cord segment.
    Neurology. 2007;69:E15.
    PubMed     Related articles   
    
    
    
36. BROWN MG , Kirby S, Skedgel C, Fisk JD, et al
    How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Neurology. 2007;69:1498-507.
    PubMed     Related articles    Abstract available
    
    
    
37. MOLL NM , Rietsch AM, Ransohoff AJ, Cossoy MB, et al
    Cortical demyelination in PML and MS: Similarities and differences.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. FREEDMAN MS , Pachner AR
    Neutralizing antibodies to biological therapies: A "touch of gray" vs a "black and white" story.
    Neurology. 2007;69:1386-7.
    PubMed     Related articles   
    
    
    
39. CALABRESI PA , Giovannoni G, Confavreux C, Galetta SL, et al
    The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL.
    Neurology. 2007;69:1391-403.
    PubMed     Related articles    Abstract available
    
    
    September 2007
40. WU GF , Schwartz ED, Lei T, Souza A, et al
    Relation of vision to global and regional brain MRI in multiple sclerosis.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. TINTORE M , Rovira A, Rio J, Tur C, et al
    Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. HADER WJ , Yee IM
    Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan.
    Neurology. 2007;69:1224-9.
    PubMed     Related articles    Abstract available
    
    
    
43. HOUTCHENS MK , Benedict RH, Killiany R, Sharma J, et al
    Thalamic atrophy and cognition in multiple sclerosis.
    Neurology. 2007;69:1213-23.
    PubMed     Related articles    Abstract available
    
    
    
44. MARROSU MG
    Parental transmission of multiple sclerosis: maternal, paternal, or neither?
    Neurology. 2007;69:1202-3.
    PubMed     Related articles   
    
    
    
45. SORMANI MP , Rovaris M, Comi G, Filippi M, et al
    A composite score to predict short-term disease activity in patients with relapsing-remitting MS.
    Neurology. 2007;69:1230-5.
    PubMed     Related articles    Abstract available
    
    
    
46. HERRERA BM , Ramagopalan SV, Orton S, Chao MJ, et al
    Parental transmission of MS in a population-based Canadian cohort.
    Neurology. 2007;69:1208-12.
    PubMed     Related articles    Abstract available
    
    
    August 2007
47. AMATO MP , De Stefano N
    Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Neurology. 2007;69:938.
    PubMed     Related articles   
    
    
    
48. ROSE JW , Burns JB, Bjorklund J, Klein J, et al
    Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
    Neurology. 2007;69:785-9.
    PubMed     Related articles    Abstract available
    
    
    
49. FLEMING JO , Keegan BM, Parisi JE
    A 52-year-old man with progressive left-sided weakness and white matter disease.
    Neurology. 2007;69:600-6.
    PubMed     Related articles   
    
    
    July 2007
50. ISLAM T , Gauderman WJ, Cozen W, Mack TM, et al
    Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins.
    Neurology. 2007;69:381-8.
    PubMed     Related articles    Abstract available
    
    
    
51. KAPLIN AI , Williams M
    How common are the "common" neurologic disorders?
    Neurology. 2007;69:410.
    PubMed     Related articles   
    
    
    
52. RINKER JR 2ND , Trinkaus K, Naismith RT, Cross AH, et al
    Higher IgG index found in African Americans versus Caucasians with multiple sclerosis.
    Neurology. 2007;69:68-72.
    PubMed     Related articles    Abstract available
    
    
    
53. PASCUAL AM , Martinez-Bisbal MC, Bosca I, Valero C, et al
    Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis.
    Neurology. 2007;69:63-7.
    PubMed     Related articles    Abstract available
    
    
    
54. SADOVNICK AD , Duquette P, Herrera B, Yee IM, et al
    A timing-of-birth effect on multiple sclerosis clinical phenotype.
    Neurology. 2007;69:60-2.
    PubMed     Related articles    Abstract available
    
    
    June 2007
55. GAUTHIER SA , Mandel M, Guttmann CR, Glanz BI, et al
    Predicting short-term disability in multiple sclerosis.
    Neurology. 2007;68:2059-65.
    PubMed     Related articles    Abstract available
    
    
    
56. THROWER BW
    Clinically isolated syndromes: predicting and delaying multiple sclerosis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
57. GUILFOYLE MR , Kirollos RW
    Tumefactive demyelinating lesion.
    Neurology. 2007;68:2155.
    PubMed     Related articles   
    
    
    
58. MARKOWITZ CE
    Interferon-beta: mechanism of action and dosing issues.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
59. COYLE PK
    Evidence-based medicine and clinical trials.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
60. NORONHA A
    Neutralizing antibodies to interferon.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
61. MARRIE RA , Cutter G, Tyry T, Vollmer T, et al
    Disparities in the management of multiple sclerosis-related bladder symptoms.
    Neurology. 2007;68:1971-8.
    PubMed     Related articles    Abstract available
    
    
    May 2007
62. ZIVADINOV R
    Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
63. KHAN O
    Can clinical outcomes be used to detect neuroprotection in multiple sclerosis?
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
64. LISAK RP
    Neurodegeneration in multiple sclerosis: defining the problem.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
65. LOEB JA
    Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
66. YONG VW , Giuliani F, Xue M, Bar-Or A, et al
    Experimental models of neuroprotection relevant to multiple sclerosis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
67. DUTTA R , Trapp BD
    Pathogenesis of axonal and neuronal damage in multiple sclerosis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
68. DHIB-JALBUT S
    Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
69. 
    Proceedings of a meeting to discuss neurodegeneration, neuroprotection and repair, and the interrelated issues of glial cells and myelin in multiple sclerosis. May 24, 2006. Geneva, Switzerland.
    Neurology. 2007;68.
    PubMed     Related articles   
    
    
    
70. ARNOLD DL
    Evidence for neuroprotection and remyelination using imaging techniques.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
71. CARTWRIGHT MS , Jeffery DR, Lewis ZT, Koty PP, et al
    Mitoxantrone for multiple sclerosis causing acute lymphoblastic leukemia.
    Neurology. 2007;68:1630-1.
    PubMed     Related articles   
    
    
    
72. DORSEY ER , Thompson JP, Noyes K, Dick AW, et al
    Quantifying the risks and benefits of natalizumab in relapsing multiple sclerosis.
    Neurology. 2007;68:1524-8.
    PubMed     Related articles    Abstract available
    
    
    
73. CHENG Q , Miao L, Zhang J, Ding SJ, et al
    A population-based survey of multiple sclerosis in Shanghai, China.
    Neurology. 2007;68:1495-500.
    PubMed     Related articles    Abstract available
    
    
    
74. SEPULCRE J , Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, et al
    Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
    Neurology. 2007;68:1488-94.
    PubMed     Related articles    Abstract available
    
    
    April 2007
75. SHI J , Zhao C, Vollmer TL, Tyry TM, et al
    APOE {varepsilon}4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Neurology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. MILLER DH , Soon D, Fernando KT, MacManus DG, et al
    MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.
    Neurology. 2007;68:1390-401.
    PubMed     Related articles    Abstract available
    
    
    
77. BELMAN AL , Chitnis T, Renoux C, Waubant E, et al
    Challenges in the classification of pediatric multiple sclerosis and future directions.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
78. KRUPP LB , Banwell B, Tenembaum S
    Consensus definitions proposed for pediatric multiple sclerosis and related disorders.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
79. MACALLISTER WS , Boyd JR, Holland NJ, Milazzo MC, et al
    The psychosocial consequences of pediatric multiple sclerosis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
80. POHL D , Waubant E, Banwell B, Chabas D, et al
    Treatment of pediatric multiple sclerosis and variants.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
81. BANWELL B , Shroff M, Ness JM, Jeffery D, et al
    MRI features of pediatric multiple sclerosis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
82. NESS JM , Chabas D, Sadovnick AD, Pohl D, et al
    Clinical features of children and adolescents with multiple sclerosis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
83. HANEFELD F
    Pediatric multiple sclerosis: A short history of a long story.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
84. HAHN JS , Pohl D, Rensel M, Rao S, et al
    Differential diagnosis and evaluation in pediatric multiple sclerosis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
85. BALCER LJ , Galetta SL, Calabresi PA, Confavreux C, et al
    Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.
    Neurology. 2007;68:1299-304.
    PubMed     Related articles    Abstract available
    
    
    
86. KISTER I , Herbert J, Swerdlow ML, Bergamaschi R, et al
    Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Neurology. 2007;68:1326-7.
    PubMed     Related articles   
    
    
    
87. IKEDA K , Araki Y, Iwasaki Y
    Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Neurology. 2007;68:1326.
    PubMed     Related articles   
    
    
    
88. WEINSHENKER BG , Jacob A
    Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
    Neurology. 2007;68:1326.
    PubMed     Related articles   
    
    
    
89. GORMAN MP , Golomb MR, Walsh LE, Hobson GM, et al
    Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation.
    Neurology. 2007;68:1305-7.
    PubMed     Related articles    Abstract available
    
    
    
90. TENEMBAUM S , Chitnis T, Ness J, Hahn JS, et al
    Acute disseminated encephalomyelitis.
    Neurology. 2007;68.
    PubMed     Related articles    Abstract available
    
    
    
91. KOCH MW , Mostert JP, de Vries JJ, De Keyser J, et al
    Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
    Neurology. 2007;68:1163.
    PubMed     Related articles   
    
    
    March 2007
92. CENTONZE D , Koch G, Versace V, Mori F, et al
    Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis.
    Neurology. 2007;68:1045-50.
    PubMed     Related articles    Abstract available
    
    
    
93. KHALILI K , White MK, Lublin F, Ferrante P, et al
    Reactivation of JC virus and development of PML in patients with multiple sclerosis.
    Neurology. 2007;68:985-90.
    PubMed     Related articles    Abstract available
    
    
    
94. GOODIN DS , Frohman EM, Hurwitz B, O'Connor PW, et al
    Neutralizing antibodies to interferon beta: assessment of their clinical and radiographic impact: an evidence report: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology. 2007;68:977-84.
    PubMed     Related articles    Abstract available
    
    
    
95. JARIUS S , Franciotta D, Bergamaschi R, Wright H, et al
    NMO-IgG in the diagnosis of neuromyelitis optica.
    Neurology. 2007;68:1076-7.
    PubMed     Related articles   
    
    
    
96. HOFFMANN LA , Krumbholz M, Faber H, Kuempfel T, et al
    Multiple sclerosis: relating MxA transcription to anti-interferon-beta-neutralizing antibodies.
    Neurology. 2007;68:958-9.
    PubMed     Related articles   
    
    
    
97. COHEN JA , Rovaris M, Goodman AD, Ladkani D, et al
    Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS.
    Neurology. 2007;68:939-44.
    PubMed     Related articles    Abstract available
    
    
    
98. MIYAZAWA I , Nakashima I, Petzold A, Fujihara K, et al
    High CSF neurofilament heavy chain levels in neuromyelitis optica.
    Neurology. 2007;68:865-7.
    PubMed     Related articles    Abstract available
    
    
    
99. STANKOFF B , Mrejen S, Tourbah A, Fontaine B, et al
    Age at onset determines the occurrence of the progressive phase of multiple sclerosis.
    Neurology. 2007;68:779-81.
    PubMed     Related articles    Abstract available
    
    
    February 2007
100. PIRKO I , Lucchinetti CF, Sriram S, Bakshi R, et al
     Gray matter involvement in multiple sclerosis.
     Neurology. 2007;68:634-42.
     PubMed     Related articles    Abstract available
     
     
     
101. KARCESKI S
     Multiple sclerosis: what have we learned?
     Neurology. 2007;68:E9-10.
     PubMed     Related articles   
     
     
     
102. WINGERCHUK DM , Pittock SJ, Lucchinetti CF, Lennon VA, et al
     A secondary progressive clinical course is uncommon in neuromyelitis optica.
     Neurology. 2007;68:603-5.
     PubMed     Related articles    Abstract available
     
     
     
103. KOUTSIS G , Panas M, Giogkaraki E, Potagas C, et al
     APOE epsilon4 is associated with impaired verbal learning in patients with MS.
     Neurology. 2007;68:546-9.
     PubMed     Related articles    Abstract available
     
     
     
104. SAYAO AL , Devonshire V, Tremlett H
     Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
     Neurology. 2007;68:496-500.
     PubMed     Related articles    Abstract available
     
     
     
105. PITTOCK SJ
     Does benign multiple sclerosis today imply benign multiple sclerosis tomorrow?: implications for treatment.
     Neurology. 2007;68:480-1.
     PubMed     Related articles   
     
     
     January 2007
106. HENSIEK AE , Seaman SR, Barcellos LF, Oturai A, et al
     Familial effects on the clinical course of multiple sclerosis.
     Neurology. 2007;68:376-83.
     PubMed     Related articles    Abstract available
     
     
     
107. LAUER K
     Multiple sclerosis frequency in Israel's diverse populations.
     Neurology. 2007;68:311.
     PubMed     Related articles   
     
     
     
108. JUREWICZ A , Matysiak M, Raine CS, Selmaj K, et al
     Soluble Nogo-A, an inhibitor of axonal regeneration, as a biomarker for multiple sclerosis.
     Neurology. 2007;68:283-7.
     PubMed     Related articles    Abstract available
     
     
     
109. PUCCIONI-SOHLER M , Yamano Y, Rios M, Carvalho SM, et al
     Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
     Neurology. 2007;68:206-13.
     PubMed     Related articles    Abstract available
     
     
     
110. DEBOUVERIE M , Lebrun C, Jeannin S, Pittion-Vouyovitch S, et al
     More severe disability of North Africans vs Europeans with multiple sclerosis in France.
     Neurology. 2007;68:29-32.
     PubMed     Related articles    Abstract available
     
     
     December 2006
111. DURELLI L , Barbero P, Clerico M
     A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
     Neurology. 2006;67:2264.
     PubMed     Related articles   
     
     
     
112. FLEMING JO , Cook TD
     Multiple sclerosis and the hygiene hypothesis.
     Neurology. 2006;67:2085-6.
     PubMed     Related articles   
     
     
     
113. POHL D , Krone B, Rostasy K, Kahler E, et al
     High seroprevalence of Epstein-Barr virus in children with multiple sclerosis.
     Neurology. 2006;67:2063-5.
     PubMed     Related articles    Abstract available
     
     
     
114. CANO SJ , O'Connor RJ, Thompson AJ, Hobart JC, et al
     Exploring disability rating scale responsiveness II: do more response options help?
     Neurology. 2006;67:2056-9.
     PubMed     Related articles    Abstract available
     
     
     November 2006
115. ZIPP F , Hartung HP, Hillert J, Schimrigk S, et al
     Blockade of chemokine signaling in patients with multiple sclerosis.
     Neurology. 2006;67:1880-3.
     PubMed     Related articles    Abstract available
     
     
     
116. DE SEZE J , Zephir H, Hautecoeur P, Mackowiak A, et al
     Pathologic laughing and intractable hiccups can occur early in multiple sclerosis.
     Neurology. 2006;67:1684-6.
     PubMed     Related articles    Abstract available
     
     
     
117. PHILLIPS JT , O'Connor PW, Havrdova E, Hutchinson M, et al
     Infusion-related hypersensitivity reactions during natalizumab treatment.
     Neurology. 2006;67:1717-8.
     PubMed     Related articles   
     
     
     
118. SORENSEN PS , Tscherning T, Mathiesen HK, Langkilde AR, et al
     Neutralizing antibodies hamper IFNbeta bioactivity and treatment effect on MRI in patients with MS.
     Neurology. 2006;67:1681-3.
     PubMed     Related articles    Abstract available
     
     
     
119. BOBHOLZ JA , Rao SM, Lobeck L, Elsinger C, et al
     fMRI study of episodic memory in relapsing-remitting MS: correlation with T2 lesion volume.
     Neurology. 2006;67:1640-5.
     PubMed     Related articles    Abstract available
     
     
     October 2006
120. ZETTL UK , Hartung HP, Pahnke A, Brueck W, et al
     Lesion pathology predicts response to plasma exchange in secondary progressive MS.
     Neurology. 2006;67:1515-6.
     PubMed     Related articles   
     
     
     
121. BENSMAIL D , Quera Salva MA, Roche N, Benyahia S, et al
     Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity.
     Neurology. 2006;67:1432-6.
     PubMed     Related articles    Abstract available
     
     
     
122. GOODIN DS
     A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
     Neurology. 2006;67:1313-4.
     PubMed     Related articles   
     
     
     
123. TREMLETT H , Seemuller S, Zhao Y, Yoshida EM, et al
     Liver test abnormalities in multiple sclerosis: findings from placebo-treated patients.
     Neurology. 2006;67:1291-3.
     PubMed     Related articles    Abstract available
     
     
     
124. RINKER JR 2ND , Trinkaus K, Cross AH
     Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis.
     Neurology. 2006;67:1288-90.
     PubMed     Related articles    Abstract available
     
     
     
125. KAPPOS L , Polman CH, Freedman MS, Edan G, et al
     Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
     Neurology. 2006;67:1242-9.
     PubMed     Related articles    Abstract available
     
     
     September 2006
126. GOODIN DS
     IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
     Neurology. 2006;67:1104.
     PubMed     Related articles   
     
     
     
127. IMRELL K , Landtblom AM, Hillert J, Masterman T, et al
     Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct.
     Neurology. 2006;67:1062-4.
     PubMed     Related articles    Abstract available
     
     
     
128. WEGNER C , Esiri MM, Chance SA, Palace J, et al
     Neocortical neuronal, synaptic, and glial loss in multiple sclerosis.
     Neurology. 2006;67:960-7.
     PubMed     Related articles    Abstract available
     
     
     
129. TREMLETT H , Devonshire V
     Is late-onset multiple sclerosis associated with a worse outcome?
     Neurology. 2006;67:954-9.
     PubMed     Related articles    Abstract available
     
     
     
130. NOSEWORTHY JH
     How much can we learn from long-term extension trials in multiple sclerosis?
     Neurology. 2006;67:930-1.
     PubMed     Related articles   
     
     
     
131. LIU HM , Hsieh WJ, Yang CC, Wu VC, et al
     Leukoencephalopathy induced by levamisole alone for the treatment of recurrent aphthous ulcers.
     Neurology. 2006;67:1065-7.
     PubMed     Related articles    Abstract available
     
     
     
132. TINTORE M , Rovira A, Rio J, Nos C, et al
     Baseline MRI predicts future attacks and disability in clinically isolated syndromes.
     Neurology. 2006;67:968-72.
     PubMed     Related articles    Abstract available
     
     
     
133. KAPPOS L , Traboulsee A, Constantinescu C, Eralinna JP, et al
     Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS.
     Neurology. 2006;67:944-53.
     PubMed     Related articles    Abstract available
     
     
     
134. YOUNG PJ , Lederer C, Eder K, Daumer M, et al
     Relapses and subsequent worsening of disability in relapsing-remitting multiple sclerosis.
     Neurology. 2006;67:804-8.
     PubMed     Related articles    Abstract available
     
     
     
135. WEST T , Wyatt M, High A, Bostrom A, et al
     Are initial demyelinating event recovery and time to second event under differential control?
     Neurology. 2006;67:809-13.
     PubMed     Related articles    Abstract available
     
     
     July 2006
136. CORREALE J , Fiol M, Gilmore W
     The risk of relapses in multiple sclerosis during systemic infections.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
137. HERNAN MA , Alonso A, Hernandez-Diaz S
     Tetanus vaccination and risk of multiple sclerosis: a systematic review.
     Neurology. 2006;67:212-5.
     PubMed     Related articles    Abstract available
     
     
     
138. KANTARCI OH , Barcellos LF, Atkinson EJ, Ramsay PP, et al
     Men transmit MS more often to their children vs women: the Carter effect.
     Neurology. 2006;67:305-10.
     PubMed     Related articles    Abstract available
     
     
     
139. WILEJTO M , Shroff M, Buncic JR, Kennedy J, et al
     The clinical features, MRI findings, and outcome of optic neuritis in children.
     Neurology. 2006;67:258-62.
     PubMed     Related articles    Abstract available
     
     
     
140. LALIVE PH , Menge T, Barman I, Cree BA, et al
     Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays.
     Neurology. 2006;67:176-7.
     PubMed     Related articles   
     
     
     
141. BENEDETTI B , Valsasina P, Judica E, Martinelli V, et al
     Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI.
     Neurology. 2006;67:161-3.
     PubMed     Related articles    Abstract available
     
     
     June 2006
142. CHEN JT , Collins DL, Atkins HL, Freedman MS, et al
     Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis.
     Neurology. 2006;66:1935-7.
     PubMed     Related articles    Abstract available
     
     
     
143. PULICKEN M , Koteish A, DeBusk K, Calabresi PA, et al
     Unmasking of autoimmune hepatitis in a patient with MS following interferon beta therapy.
     Neurology. 2006;66:1954-5.
     PubMed     Related articles   
     
     
     
144. TENEMBAUM SN , Segura MJ
     Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis.
     Neurology. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
145. KOBELT G , Berg J, Atherly D, Hadjimichael O, et al
     Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States.
     Neurology. 2006;66:1696-702.
     PubMed     Related articles    Abstract available
     
     
     May 2006
146. RUBIERA M , Rio J, Tintore M, Nos C, et al
     Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis.
     Neurology. 2006;66:1568-70.
     PubMed     Related articles    Abstract available
     
     
     
147. WINGERCHUK DM , Lennon VA, Pittock SJ, Lucchinetti CF, et al
     Revised diagnostic criteria for neuromyelitis optica.
     Neurology. 2006;66:1485-9.
     PubMed     Related articles    Abstract available
     
     
     
148. KERR DA
     The lumping and splitting of inflammatory CNS diseases.
     Neurology. 2006;66:1466-7.
     PubMed     Related articles   
     
     
     
149. LI DK , Held U, Petkau J, Daumer M, et al
     MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability.
     Neurology. 2006;66:1384-9.
     PubMed     Related articles    Abstract available
     
     
     
150. BURWICK RM , Ramsay PP, Haines JL, Hauser SL, et al
     APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
     Neurology. 2006;66:1373-83.
     PubMed     Related articles    Abstract available
     
     
     
151. NADEAU SE
     Effect of mitoxantrone on MRI in progressive MS: results of the MIMS trial.
     Neurology. 2006;66:1457-8.
     PubMed     Related articles   
     
     
     April 2006
152. LAPLAUD DA , Leray E, Barriere P, Wiertlewski S, et al
     Increase in multiple sclerosis relapse rate following in vitro fertilization.
     Neurology. 2006;66:1280-1.
     PubMed     Related articles   
     
     
     
153. TIPPMANN-PEIKERT M , Boeve BF, Keegan BM
     REM sleep behavior disorder initiated by acute brainstem multiple sclerosis.
     Neurology. 2006;66:1277-9.
     PubMed     Related articles   
     
     
     
154. MARRIE RA , Cutter G, Tyry T, Vollmer T, et al
     Does multiple sclerosis-associated disability differ between races?
     Neurology. 2006;66:1235-40.
     PubMed     Related articles    Abstract available
     
     
     
155. ALTER M , Kahana E, Zilber N, Miller A, et al
     Multiple sclerosis frequency in Israel's diverse populations.
     Neurology. 2006;66:1061-6.
     PubMed     Related articles    Abstract available
     
     
     March 2006
156. KIESEIER BC , Hartung HP
     Polyneuropathy associated with interferon beta treatment in patients with multiple sclerosis.
     Neurology. 2006;66:955.
     PubMed     Related articles   
     
     
     
157. O'CONNOR PW , Li D, Freedman MS, Bar-Or A, et al
     A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
     Neurology. 2006;66:894-900.
     PubMed     Related articles    Abstract available
     
     
     
158. DALTON CM , Miszkiel KA, O'Connor PW, Plant GT, et al
     Ventricular enlargement in MS: one-year change at various stages of disease.
     Neurology. 2006;66:693-8.
     PubMed     Related articles    Abstract available
     
     
     
159. SCHWID SR , Cutter GR
     Futility studies: spending a little to save a lot.
     Neurology. 2006;66:626-7.
     PubMed     Related articles   
     
     
     February 2006
160. MASJUAN J , Alvarez-Cermeno JC, Garcia-Barragan N, Diaz-Sanchez M, et al
     Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
     Neurology. 2006;66:576-8.
     PubMed     Related articles    Abstract available
     
     
     
161. PACHNER AR , Narayan K, Pak E
     Multiplex analysis of expression of three IFNbeta-induced genes in antibody-positive MS patients.
     Neurology. 2006;66:444-6.
     PubMed     Related articles    Abstract available
     
     
     December 2005
162. RAMMOHAN KW , Lynn DJ
     Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
     Neurology. 2005;65:1995-7.
     PubMed     Related articles   
     
     
     
163. KRAFT GH , Bowen J
     Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study.
     Neurology. 2005;65:1995-7.
     PubMed     Related articles   
     
     
     
164. MELLION ML , Rizvi S
     Spontaneous bilateral carotid artery dissection and posterior reversible encephalopathy syndrome.
     Neurology. 2005;65:1990.
     PubMed     Related articles   
     
     
     
165. TREMLETT H , Paty D, Devonshire V
     The natural history of primary progressive MS in British Columbia, Canada.
     Neurology. 2005;65:1919-23.
     PubMed     Related articles    Abstract available
     
     
     
166. HELD U , Heigenhauser L, Shang C, Kappos L, et al
     Predictors of relapse rate in MS clinical trials.
     Neurology. 2005;65:1769-73.
     PubMed     Related articles    Abstract available
     
     
     November 2005
167. MISU T , Fujihara K, Nakashima I, Sato S, et al
     Intractable hiccup and nausea with periaqueductal lesions in neuromyelitis optica.
     Neurology. 2005;65:1479-82.
     PubMed     Related articles    Abstract available
     
     
     
168. BARKHOF F , Held U, Simon JH, Daumer M, et al
     Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trials.
     Neurology 2005;65:1447-54.
     PubMed     Related articles    Abstract available
     
     
     October 2005
169. LONGSTRETH WT JR , Swanson PD
     Scanning speech and word history.
     Neurology. 2005;65:1328.
     PubMed     Related articles   
     
     

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Bernd Sebastian Kamps website.    Design: